MY179479A - "tocoolag -onan oros antimicrobial" a liposome drug delivery system - Google Patents

"tocoolag -onan oros antimicrobial" a liposome drug delivery system

Info

Publication number
MY179479A
MY179479A MYPI2013002990A MYPI2013002990A MY179479A MY 179479 A MY179479 A MY 179479A MY PI2013002990 A MYPI2013002990 A MY PI2013002990A MY PI2013002990 A MYPI2013002990 A MY PI2013002990A MY 179479 A MY179479 A MY 179479A
Authority
MY
Malaysia
Prior art keywords
composition
tocoolag
onan
oros
antimicrobial
Prior art date
Application number
MYPI2013002990A
Inventor
Kim Seng Chai
Original Assignee
Kim Seng Chai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kim Seng Chai filed Critical Kim Seng Chai
Priority to MYPI2013002990A priority Critical patent/MY179479A/en
Publication of MY179479A publication Critical patent/MY179479A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The present invention is directed to a composition comprising silver nanoparticle enclosed by phospholipid derived from tocotrienol rich fraction of palm oil, hyaluronic acid and a surfactant. . The composition forms a water base solution to apply by ways of spraying or other delivery methods in a form of patch, cream, trans-dermal or intra-10 dermal injection, inhalation device and drug-eluting disk. The present invention enhances functionality of an active ingredient, in which the composition is useful for improving microbial-resistant and water-solubility of the active ingredient. The composition can be used as a single entity or in combination with a device or a biological component, for a medical or pharmaceutical application. (The most illustrative figure: Figure 1)
MYPI2013002990A 2013-08-14 2013-08-14 "tocoolag -onan oros antimicrobial" a liposome drug delivery system MY179479A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2013002990A MY179479A (en) 2013-08-14 2013-08-14 "tocoolag -onan oros antimicrobial" a liposome drug delivery system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2013002990A MY179479A (en) 2013-08-14 2013-08-14 "tocoolag -onan oros antimicrobial" a liposome drug delivery system

Publications (1)

Publication Number Publication Date
MY179479A true MY179479A (en) 2020-11-08

Family

ID=79181479

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2013002990A MY179479A (en) 2013-08-14 2013-08-14 "tocoolag -onan oros antimicrobial" a liposome drug delivery system

Country Status (1)

Country Link
MY (1) MY179479A (en)

Similar Documents

Publication Publication Date Title
SG10201810888XA (en) Compositions and methods comprising bupropion or related compounds and dextromethorphan
MY188825A (en) High-concentration monoclonal antibody formulations
WO2017049083A3 (en) Delivery of drug nanoparticles and methods of use thereof
WO2012160180A3 (en) Pharmaceutical composition for administration to nails
WO2009129464A3 (en) Method for treating acute pain with a formulated drug depot in combination with a liquid formulation
UA113962C2 (en) PHARMACEUTICAL COMPOSITION CONTAINING APOMORPHINE AS AN ACTIVE INGREDIENT
EP4309735A3 (en) Pharmaceutical composition of s-ketamine hydrochloride
MX2013003635A (en) N-heteroaryl compounds.
BR112018013979A2 (en) gel compositions for transdermal delivery to maximize drug concentrations in the stratum corneum and serum and methods of use thereof
MY169099A (en) Injectable formulation
MX2017004772A (en) Compositions and methods for physiological delivery using cannabidiol.
NZ702342A (en) Pharmaceutical formulation
UA117480C2 (en) Treatment of diabetes mellitus by long–acting formulations of insulins
PH12015502556A1 (en) Modified release formulation
TN2017000011A1 (en) Aqueous formulation comprising paracetamol and ibuprofen.
WO2015001163A3 (en) Lipid nanoparticles for healing wounds
BR112012028047A2 (en) catheter system, catheter, method of administering an agent to a patient and method for varying an active agent dosage
MX2013013691A (en) A sustained -release composition containing a melanocortin receptor ligand as the active ingredient.
CA2818951A1 (en) Human lactoferrin derived peptide for use as an antigen masking agent
ZA201404068B (en) The use of silver(i) complexes as active pharmaceutical ingredients (api's) iincluding anticancer agents
MX2014014579A (en) O/w-emulsion-type topical pharmaceutical compositions containing a retinoid.
TR201911194T4 (en) It is an inhalable drug.
MY179479A (en) "tocoolag -onan oros antimicrobial" a liposome drug delivery system
GB201204632D0 (en) Delivery system
BR112015020182A2 (en) cosmetic use of cheuin or a precursor or derivative thereof as an active ingredient, use of cheuin or a precursor or derivative thereof as an active ingredient, cosmetic composition and cosmetic treatment process to prevent and / or treat signs of skin aging and / or cutaneous attachments